Determinants of Right Ventricular Failure in Patients Admitted With Acute Left Heart Failure

Congestive Heart Failure

Volumn 16, Issue 6, 2010, Pages 243-248

  Berkowitz, Robert ^a   Alhaj, Eyad ^a   Manchikalapudi, Rama Bindu ^a   Satya, Kumar ^a   Dadfarmay, Sina ^a   Zakir, Ramzan ^b  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b Robert Wood Johnson Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART RIGHT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ACUTE DISEASE; AGED; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EPIDEMIOLOGIC FACTORS; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; MALE; PREVALENCE; PROGNOSIS; PULMONARY ARTERY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 78649454163     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00184.x     Document Type: Article

References (25)

1. Zakir RM, Al-Dehneh A, Maher J, et al. Right ventricular failure in patients with preserved ejection fraction and diastolic dysfunction: an underrecognized clinical entity. Congest Heart Fail. 2007;13(3):164-169.
2. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29(1):153-159.
3. Capomolla S, Febo O, Guazzotti G, et al. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant. 2000;19:426-437.
4. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22:107.
5. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70(4):657-662.
6. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66(4):493-496.
7. Puwanant S, Priester TC, Mookadam F, et al. Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr. 2009;10(6):733-737.
8. Hemnes AR, Forfia PR, Champion HC. Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl. 2009;162:4-19.
9. Centers for disease control and prevention, mortality from congestive heart failure-United States, 1980-1990. JAMA. 1994;271: 813-814.
10. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 1994;72(2 suppl):S3-S9.
11. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134(7):550-560.
12. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296(18):2209-2216.
13. Neuman Y, Kotliroff A, Bental T, et al. Pulmonary artery pressure and diastolic dysfunction in normal left ventricular systolic function. Int J Cardiol. 2008;127(2):174-178.
14. Kjaergaard J, Akkan D, Iversen KK, et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol. 2007;99(8):1146-1150.
15. Di Salvo TG, Mathie M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995;25(5):1143-1153.
16. Kjaergaard J, Akkan D, Iversen KK, et al. Right ventricular dysfunction as an independent predictor of short and long-term mortality in patients with heart failure. Eur J Heart Fail. 2007;9(6-7):610-616.
17. De Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998;32(4):948-954.
18. Capomolla S, Febo O, Guazzotti G, et al. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant. 2000;19(5):426-438.
19. Lewis GD, Lachmann J, Camuso J, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation. 2007;115(1):59-66.
20. Guazzi M, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol. 2004;44(12):2339-2348.
21. Guazzi M, Samaja M, Arena R, et al. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007;50(22):2136-2144.
22. Phosphodiesterase-5 Inhibition to improve clinical status and exercise capacity in diastolic heart failure (RELAX). Available at: Accessed March 3, 2009.
23. Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134(1):44-54.
24. Packer M. Effects of the endothelin antagonist bosentan on the morbidity and mortality in patients with chronic heart failure. Results of the ENABLE 1 and 2 trial program. Presented at the American College of Cardiology Meeting. March 2002; Atlanta, GA.
25. Sallach JA, Tang WH, Borowski AG, et al. Right atrial volume index in chronic systolic heart failure and prognosis. JACC Cardiovasc Imaging. 2009;2(5):527-534.